Skip to main content

Table 3 Comparison of short-term and long-term mortality as a function of AACCI (age-adjusted Charlson comorbidity index)

From: Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study

Time

AACCI

Survival %*

95% CI

p

6 months

2–5

97,40%

(92,1%; 99,1%)

0,176

6–10

93,10%

(82,7%; 97,4%)

12 months

2–5

86,00%

(78,1%; 91,2%)

0,579

6–10

82,80%

(70,3%; 90,3%)

18 months

2–5

78,90%

(70,3%; 85,4%)

0,153

6–10

69,00%

(55,4%; 79,2%)

24 months

2–5

71,90%

(62,7%; 79,2%)

0,123

6–10

60,30%

(46,6%;71,6%)

36 months

2–5

55,50%

(45,8%; 64,2%)

0,021

6–10

36,90%

(24,5%; 49,3%)

  1. *The proportions of patients who survived at a given timepoint was derived from the Kaplan-Meier method with corresponding two-sided 95% CIs and p-values